3M Articles

3M's Aldara delayed for skin cancer

19 April 2004

$1.3M studies award for eResearchTechnology

5 April 2004

ExonHit completes 8.3M-euro funding

9 February 2004

Advancis achieves $3M GSK milestone

19 January 2004

IVAX confirms 3M product deal

27 October 2003

Lab International to buy Canada's Seyvika for $3M

13 October 2003

Biomira completes $16.3M financing

13 October 2003

Vion in $11.3M private placement accords

15 September 2003

Guilford sells $9.3M notes

11 August 2003

IVAX expands respiratory franchise in Europe

21 July 2003

3M files sNDA for Aldara

12 May 2003

Dimethaid closes C$9.3M rights offer

28 April 2003

Ranbaxy gets OK for generic Tambocor

7 April 2003

James McNerney joins P&G's board

24 March 2003

3M on track to file Aldara for skin lesions in mid '03

17 March 2003

Pharmos sells $4.3M of common stock

10 March 2003

Lilly, 3M stop resiquimod trial in herpes

3 March 2003

Omega set to continue on expansion trail

20 January 2003

Marketing Authorization withdrawal of Zartra

12 August 2002

MelTec wins grant worth 2.3M euros

15 July 2002

Dionex to make $3m invesment in PharmaSeq

27 May 2002

Tokyo pharma stocks - week to April 29

6 May 2002

IVAX expands US asthma products line with 3M's QVAR brand

8 April 2002

MediGene says wart drug cuts recurrence

14 January 2002

MediGene drug discovery platform and pipeline hold promise, say analysts

28 November 2001

Eli Lilly to miss earnings targets as Prozac sales collapse; confident about

4 October 2001

Japan pharma stocks - week to July 16

18 July 2001

Inpharmatica placement raises L31.3M

5 July 2001

Acambis gets $1.3M grant for vaccine R&D

29 June 2001

Positive Ph II data for 3M's Aldara

1 June 2001

Novelos completes $3.3M private financing

16 November 2000

Pivotal trials start for 3M's antiherpes agent

6 November 2000

3M's QVAR inhaler cleared in USA

19 September 2000

Appointment at IVAX

8 June 2000

Appointment at Curatek Pharmaceuticals

25 May 2000

Appointment at 3M

17 February 2000

1999 mergers suggest move away from life sciences concept to pharmaceuticals

6 January 2000

Appointment at 3M Pharmaceuticals

10 November 1999

3M sets up new drug delivery system business in USA

2 November 1999

Progenics awarded $3m for HIV research

5 August 1999

3M looking for beclomethasone partner

2 July 1999

Stock Commentary Tokyo

6 May 1999

Stock Commentary Tokyo

22 April 1999

Managed care in the UK NHS: does pharma industry have a role?

12 April 1999

3M patent revoked in Europe after IVAX challenge

21 January 1999

Vanguard Discontinues Renal Failure Drug

11 December 1998

Stock Commentary New York

10 December 1998

IVAX Claims Victory In Euro Inhaler Dispute

8 December 1998

B-MS To Take Up To $500M 4th-Qtr Charge

18 November 1998

CFC-Free Flunisolide

10 September 1998

IVAX Wins In B-MS And 3M Patent Cases

28 August 1998

HMR And 3M In Alliance

12 March 1998

Appointment At 3M Pharmaceuticals

12 March 1998

3M's Aldara: New Trial Results

19 February 1998

1997: Another Good Year For New Chemical Entities

6 January 1998

Allegiance Have 3m Share Buyback

13 November 1997

Premier Enters Into 3 7-Year Partnerships

29 October 1997

Norton Claims MDI Propellant Victory

17 July 1997

UK Industry Code Of Practice In 1996

24 March 1997

US Jury Awards $2.3m Against CellPro In Patent Dispute

17 March 1997

FDA And EPA Join Forces To Stamp Out CFCs

17 March 1997

First Approval Of 3M's Genital Wart Product

10 March 1997

TACTIC Study Supports MDI Switching In Asthma

11 November 1996

3M's Hopes For Drug Delivery Systems

9 September 1996

Quadrant L6.3M Placing

17 June 1996

3M Wins Patent Battle

1 April 1996

Further Evidence That Breast Implants Are Safe

11 March 1996

Go-Ahead For Generic Albuterol In USA

8 January 1996

Many US Biotech Firms See Good 3rd Qtr Sales Growth

13 November 1995

UK Code Of Practice Amendments, New Report

25 September 1995

UK DoH Starts Talks On Slimming Drugs

15 May 1995

3M Launches CFC-Free Inhaler In UK

10 April 1995

Airomir Launch In UK

3 April 1995

RDL, The Rising Star In Contract Detailing

24 October 1994

R-PR TO COPROMOTE 3M'S INHALER

8 August 1994

3M PHARMA TO FILE NDA

20 June 1994

NON CFC INHALER TRIAL

30 May 1994

WHA CONCERN OVER COSTS OF NEW AIDS PLAN

16 May 1994

US CHEMICAL/DRUG COs SHOW 1st QTR GROWTH

9 May 1994

KNOLL'S RYTHMOL BACKED BY FDA PANEL

4 April 1994

CURRENCY AND CHARGES IMPACT 1993 US RESULTS

7 February 1994

DAIICHI AND 3M AGREEMENT

31 January 1994

PAR PHARMA AGREEMENT FOR GENERICS

31 January 1994

PHARMA RESOURCES SETTLES SUIT

17 January 1994

AUTOHALER AVAILABLE WITH NEW DRUGS

1 November 1993

GLAXO SEND LETTER TO MDI

25 October 1993

SMALLER US COMPANIES POST MIXED RESULTS

16 August 1993

STRONG GROWTH BY US PHARMA COs IN 1st QTR

10 May 1993

PRETAX PROFIT LEAPS AT MEDEVA115%AT MEDEVA IN 1992

15 March 1993

J&J SETTLES IN 3M DISPUTE

12 October 1992

RESTRUCTURING IMPROVES AMERSHAM

15 June 1992

GOOD 1st QTRs for ALZA, IMMUNEX AND MYLAN

4 May 1992

AEROBEC AUTOHALER EXTENSION

10 February 1992

STOCK MARKET COMMENTARY: NEW YORK

3 February 1992

GOOD 1991 RESULTS FOR MERCK AND FOREST LABS

3 February 1992

UK INTRO FOR 3M'S AEROBEC AUTOHALER

13 January 1992

Tianyin begins $3M repurchase program